Graham McIlroy

NIHR Academic Clinical Lecturer in Haematology

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Graham McIlroy is an NIHR Academic Clinical Lecturer in Haematology at the University of Birmingham, UK. His research focuses on the clinical management of haematological malignancies, immunotherapy, and the impact of COVID-19 on immunocompromised patients. Recent publications include studies on monoclonal immunoglobulin measurement in multiple myeloma, the implementation of Bayesian power priors in clinical trials, and the effectiveness of COVID-19 vaccine strategies in patients with suboptimal immunity.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (19)

Rita J Perry

University of Birmingham

UNITED KINGDOM

Graham McIlroy

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trial

The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial.

Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial.

The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline

Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia.

Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT)

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial.

Robust generation of neutralising antibodies against omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years.

Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people.

COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.

Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial.

Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial.

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients.

Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.

Collaborators (19)

Rita J Perry

Paul Moss

Tim Illidge

Sally Barrington

Richard J. Buka

Grace Tyson

Guy Pratt

Rodothea Amerikanou

Hayder Hussein

Dorothee P. Auer

Helen Parry

Andrea Kuhnl

Hayden Pearce

Aimee Jackson

Katharine Lewis

Kieran Woolcock

Matthew Wilson

Christopher Paul Fox

Stefanie Thust

Make your next move.